Back to Search
FRANK CZERWIEC, MD, PHD
MD, PHD
Endocrinology, Diabetes & Metabolism Physician
NPI: 1215048095Individual
Specialties, Licenses & Credentials
Endocrinology, Diabetes & Metabolism PhysicianPrimary
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
D0046791(MD)
Research & Publications (7)
Double-blind, placebo-controlled, multicenter trial of a vasopressin V2-receptor antagonist in patients with schizophrenia and hyponatremia.
PMID 18692175·Biol Psychiatry·2008
4-observational
Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia.
PMID 17105757·N Engl J Med·2006
3-trial
Vasopressin v(2) receptor blockade with tolvaptan versus fluid restriction in the treatment of hyponatremia.
PMID 16563917·Am J Cardiol·2006
4-observational
Efficacy and tolerability of a selective alpha(2C)-adrenergic receptor blocker in recovery from cold-induced vasospasm in scleroderma patients: a single-center, double-blind, placebo-controlled, randomized crossover study.
PMID 15593189·Arthritis Rheum·2004
3-trial
Cilostazol and dipyridamole synergistically inhibit human platelet aggregation.
PMID 15243309·J Cardiovasc Pharmacol·2004
3-trial
Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial.
PMID 12742979·Circulation·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2440 RESEARCH BLVD, 3RD FLOOR, CLINICAL DEVELOPMENT
ROCKVILLE, MD 20850 - Phone
- (240) 683-3523
Quick Facts
- NPI
- 1215048095
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 7
Are you this provider?
Claim Your Profile